Precision dosing is providing the right drug at the right dose for the right patient at the right time. Biosimulation, Certara’s model-based drug development, now plays a pivotal role in achieving that goal and moving the industry away from the one size fits all approach to drug delivery. The concept of accounting for individual variability is central to Certara’s use of biosimulation technology for drug development. By modelling how a drug will interact with the body, and how the body will interact with a drug, Certara can now inform on dose and dose regimen, drug-drug interactions, food effect and other ‘personalized’ impacts.
US & Canadian Academy of Pathology (USCAP)